Found: 15
Select item for more details and to access through your institution.
Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 7, p. 1, doi. 10.1038/s41419-020-02780-8
- By:
- Publication type:
- Article
Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 10, p. 1, doi. 10.1038/s41419-018-1069-9
- By:
- Publication type:
- Article
The Physical Mundane as Topos: Walking/ Dwelling/Using as Rhetorical Invention.
- Published in:
- College Composition & Communication, 2016, v. 68, n. 2, p. 266, doi. 10.58680/ccc201628881
- By:
- Publication type:
- Article
Mergers and acquisitions: A consideration of the drivers and hurdles.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 2, p. 147, doi. 10.5912/jcb425
- By:
- Publication type:
- Article
Mapping Use, Storytelling, and Experience Design.
- Published in:
- Journal of Business & Technical Communication, 2018, v. 32, n. 2, p. 198, doi. 10.1177/1050651917746708
- By:
- Publication type:
- Article
Taxonomies, Folksonomies, and Semantics: Establishing Functional Meaning in Navigational Structures.
- Published in:
- Journal of Technical Writing & Communication, 2012, v. 42, n. 3, p. 249, doi. 10.2190/TW.42.3.d
- By:
- Publication type:
- Article
Author Correction: Supporting US public health experts.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Supporting US public health experts.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1252, doi. 10.1093/neuonc/noab082
- By:
- Publication type:
- Article
Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 189, doi. 10.1093/neuonc/noaa253
- By:
- Publication type:
- Article
ACTR-71. PHASE 1/2 STUDY OF DIANHYDROGALACTITOL (VAL-083) WITH RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi27, doi. 10.1093/neuonc/noy148.101
- By:
- Publication type:
- Article
CSIG-02. VAL-083 INHIBITS PROLIFERATION OF A PANEL OF EIGHT GLIOBLASTOMA STEM CELL LINES: DOWNREGULATION OF BDR4 AS A NOVEL ANTI-NEOPLASTIC MECHANISM.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi43, doi. 10.1093/neuonc/noy148.168
- By:
- Publication type:
- Article
ACTR-27. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi17, doi. 10.1093/neuonc/noy148.060
- By:
- Publication type:
- Article
EXTH-25. DIANHYDROGALACTITOL (VAL-083) REDUCES GLIOBLASTOMA TUMOR GROWTH IN VIVO, UPON BEVACIZUMAB-INDUCED HYPOXIA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi90, doi. 10.1093/neuonc/noy148.374
- By:
- Publication type:
- Article
EXTH-09. DIANHYDROGALACTITOL (VAL-083) HAS THE POTENTIAL TO OVERCOME MAJOR CHALLENGES IN THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG).
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi86, doi. 10.1093/neuonc/noy148.358
- By:
- Publication type:
- Article